id	sid	tid	token	lemma	pos
ajlm-1713	1	1	results	result	VERB
ajlm-1713	1	2	about	about	ADP
ajlm-1713	1	3	the	the	DET
ajlm-1713	1	4	author(s	author(s	NOUN
ajlm-1713	1	5	)	)	PUNCT
ajlm-1713	1	6	asmaa	asmaa	PROPN
ajlm-1713	1	7	m.	m.	PROPN
ajlm-1713	1	8	zahran	zahran	PROPN
ajlm-1713	1	9	department	department	PROPN
ajlm-1713	1	10	of	of	ADP
ajlm-1713	1	11	clinical	clinical	ADJ
ajlm-1713	1	12	pathology	pathology	NOUN
ajlm-1713	1	13	,	,	PUNCT
ajlm-1713	1	14	south	south	PROPN
ajlm-1713	1	15	egypt	egypt	PROPN
ajlm-1713	1	16	cancer	cancer	PROPN
ajlm-1713	1	17	institute	institute	PROPN
ajlm-1713	1	18	,	,	PUNCT
ajlm-1713	1	19	assiut	assiut	PROPN
ajlm-1713	1	20	university	university	PROPN
ajlm-1713	1	21	,	,	PUNCT
ajlm-1713	1	22	assiut	assiut	PROPN
ajlm-1713	1	23	,	,	PUNCT
ajlm-1713	1	24	egypt	egypt	PROPN
ajlm-1713	1	25	hanaa	hanaa	PROPN
ajlm-1713	1	26	nafady	nafady	ADJ
ajlm-1713	1	27	-	-	PUNCT
ajlm-1713	1	28	hego	hego	ADJ
ajlm-1713	1	29	department	department	NOUN
ajlm-1713	1	30	of	of	ADP
ajlm-1713	1	31	microbiology	microbiology	NOUN
ajlm-1713	1	32	and	and	CCONJ
ajlm-1713	1	33	immunology	immunology	NOUN
ajlm-1713	1	34	,	,	PUNCT
ajlm-1713	1	35	faculty	faculty	NOUN
ajlm-1713	1	36	of	of	ADP
ajlm-1713	1	37	medicine	medicine	NOUN
ajlm-1713	1	38	,	,	PUNCT
ajlm-1713	1	39	assiut	assiut	PROPN
ajlm-1713	1	40	university	university	PROPN
ajlm-1713	1	41	,	,	PUNCT
ajlm-1713	1	42	assiut	assiut	PROPN
ajlm-1713	1	43	,	,	PUNCT
ajlm-1713	1	44	egypt	egypt	PROPN
ajlm-1713	1	45	sawsan	sawsan	PROPN
ajlm-1713	1	46	m.	m.	PROPN
ajlm-1713	1	47	moeen	moeen	PROPN
ajlm-1713	1	48	department	department	PROPN
ajlm-1713	1	49	of	of	ADP
ajlm-1713	1	50	internal	internal	ADJ
ajlm-1713	1	51	medicine	medicine	NOUN
ajlm-1713	1	52	,	,	PUNCT
ajlm-1713	1	53	clinical	clinical	ADJ
ajlm-1713	1	54	haematology	haematology	NOUN
ajlm-1713	1	55	unit	unit	NOUN
ajlm-1713	1	56	,	,	PUNCT
ajlm-1713	1	57	faculty	faculty	NOUN
ajlm-1713	1	58	of	of	ADP
ajlm-1713	1	59	medicine	medicine	NOUN
ajlm-1713	1	60	,	,	PUNCT
ajlm-1713	1	61	assiut	assiut	PROPN
ajlm-1713	1	62	university	university	PROPN
ajlm-1713	1	63	,	,	PUNCT
ajlm-1713	1	64	assiut	assiut	PROPN
ajlm-1713	1	65	,	,	PUNCT
ajlm-1713	1	66	egypt	egypt	PROPN
ajlm-1713	1	67	hanan	hanan	PROPN
ajlm-1713	1	68	a.	a.	PROPN
ajlm-1713	1	69	eltyb	eltyb	PROPN
ajlm-1713	1	70	department	department	PROPN
ajlm-1713	1	71	of	of	ADP
ajlm-1713	1	72	medical	medical	ADJ
ajlm-1713	1	73	oncology	oncology	NOUN
ajlm-1713	1	74	,	,	PUNCT
ajlm-1713	1	75	south	south	PROPN
ajlm-1713	1	76	egypt	egypt	PROPN
ajlm-1713	1	77	cancer	cancer	PROPN
ajlm-1713	1	78	institute	institute	PROPN
ajlm-1713	1	79	,	,	PUNCT
ajlm-1713	1	80	assiut	assiut	PROPN
ajlm-1713	1	81	university	university	PROPN
ajlm-1713	1	82	,	,	PUNCT
ajlm-1713	1	83	assiut	assiut	PROPN
ajlm-1713	1	84	,	,	PUNCT
ajlm-1713	1	85	egypt	egypt	PROPN
ajlm-1713	1	86	mohammed	mohammed	PROPN
ajlm-1713	1	87	m.	m.	PROPN
ajlm-1713	1	88	wahman	wahman	PROPN
ajlm-1713	1	89	department	department	PROPN
ajlm-1713	1	90	of	of	ADP
ajlm-1713	1	91	clinical	clinical	ADJ
ajlm-1713	1	92	oncology	oncology	NOUN
ajlm-1713	1	93	,	,	PUNCT
ajlm-1713	1	94	south	south	PROPN
ajlm-1713	1	95	valley	valley	PROPN
ajlm-1713	1	96	university	university	PROPN
ajlm-1713	1	97	,	,	PUNCT
ajlm-1713	1	98	qena	qena	PROPN
ajlm-1713	1	99	,	,	PUNCT
ajlm-1713	1	100	egypt	egypt	PROPN
ajlm-1713	1	101	asmaa	asmaa	PROPN
ajlm-1713	1	102	nafady	nafady	PROPN
ajlm-1713	1	103	department	department	PROPN
ajlm-1713	1	104	of	of	ADP
ajlm-1713	1	105	clinical	clinical	ADJ
ajlm-1713	1	106	and	and	CCONJ
ajlm-1713	1	107	chemical	chemical	ADJ
ajlm-1713	1	108	pathology	pathology	NOUN
ajlm-1713	1	109	,	,	PUNCT
ajlm-1713	1	110	qena	qena	PROPN
ajlm-1713	1	111	faculty	faculty	NOUN
ajlm-1713	1	112	of	of	ADP
ajlm-1713	1	113	medicine	medicine	NOUN
ajlm-1713	1	114	,	,	PUNCT
ajlm-1713	1	115	south	south	PROPN
ajlm-1713	1	116	valley	valley	PROPN
ajlm-1713	1	117	university	university	PROPN
ajlm-1713	1	118	,	,	PUNCT
ajlm-1713	1	119	qena	qena	PROPN
ajlm-1713	1	120	,	,	PUNCT
ajlm-1713	1	121	egypt	egypt	PROPN
ajlm-1713	1	122	citation	citation	PROPN
ajlm-1713	1	123	zahran	zahran	PROPN
ajlm-1713	1	124	am	be	AUX
ajlm-1713	1	125	,	,	PUNCT
ajlm-1713	1	126	nafady	nafady	ADJ
ajlm-1713	1	127	-	-	PUNCT
ajlm-1713	1	128	hego	hego	ADJ
ajlm-1713	1	129	h	h	NOUN
ajlm-1713	1	130	,	,	PUNCT
ajlm-1713	1	131	moeen	moeen	PROPN
ajlm-1713	1	132	sm	sm	PROPN
ajlm-1713	1	133	,	,	PUNCT
ajlm-1713	1	134	eltyb	eltyb	VERB
ajlm-1713	1	135	ha	ha	INTJ
ajlm-1713	1	136	,	,	PUNCT
ajlm-1713	1	137	wahman	wahman	ADJ
ajlm-1713	1	138	mm	mm	PROPN
ajlm-1713	1	139	,	,	PUNCT
ajlm-1713	1	140	nafady	nafady	ADJ
ajlm-1713	1	141	a.	a.	NOUN
ajlm-1713	1	142	corrigendum	corrigendum	NOUN
ajlm-1713	1	143	:	:	PUNCT
ajlm-1713	1	144	higher	high	ADJ
ajlm-1713	1	145	proportion	proportion	NOUN
ajlm-1713	1	146	of	of	ADP
ajlm-1713	1	147	non	non	ADJ
ajlm-1713	1	148	-	-	ADJ
ajlm-1713	1	149	classical	classical	ADJ
ajlm-1713	1	150	and	and	CCONJ
ajlm-1713	1	151	intermediate	intermediate	ADJ
ajlm-1713	1	152	monocytes	monocyte	NOUN
ajlm-1713	1	153	in	in	ADP
ajlm-1713	1	154	newly	newly	ADV
ajlm-1713	1	155	diagnosed	diagnose	VERB
ajlm-1713	1	156	multiple	multiple	ADJ
ajlm-1713	1	157	myeloma	myeloma	NOUN
ajlm-1713	1	158	patients	patient	NOUN
ajlm-1713	1	159	in	in	ADP
ajlm-1713	1	160	egypt	egypt	PROPN
ajlm-1713	1	161	:	:	PUNCT
ajlm-1713	1	162	a	a	DET
ajlm-1713	1	163	possible	possible	ADJ
ajlm-1713	1	164	prognostic	prognostic	ADJ
ajlm-1713	1	165	marker	marker	NOUN
ajlm-1713	1	166	.	.	PUNCT
ajlm-1713	2	1	afr	afr	PROPN
ajlm-1713	2	2	j	j	PROPN
ajlm-1713	2	3	lab	lab	PROPN
ajlm-1713	2	4	med	med	PROPN
ajlm-1713	2	5	.	.	PUNCT
ajlm-1713	3	1	2022;11(1	2022;11(1	NUM
ajlm-1713	3	2	)	)	PUNCT
ajlm-1713	4	1	,	,	PUNCT
ajlm-1713	4	2	a1713	a1713	PROPN
ajlm-1713	4	3	.	.	PUNCT
ajlm-1713	4	4	https://doi.org/10.4102/ajlm.v11i1.1713	https://doi.org/10.4102/ajlm.v11i1.1713	PRON
ajlm-1713	4	5	note	note	VERB
ajlm-1713	4	6	:	:	PUNCT
ajlm-1713	4	7	doi	doi	NOUN
ajlm-1713	4	8	of	of	ADP
ajlm-1713	4	9	original	original	ADJ
ajlm-1713	4	10	article	article	NOUN
ajlm-1713	4	11	published	publish	VERB
ajlm-1713	4	12	:	:	PUNCT
ajlm-1713	4	13	https://doi.org/10.4102/ajlm.v10i1.1296	https://doi.org/10.4102/ajlm.v10i1.1296	X
ajlm-1713	4	14	.	.	PUNCT
ajlm-1713	5	1	correction	correction	PROPN
ajlm-1713	5	2	corrigendum	corrigendum	NOUN
ajlm-1713	5	3	:	:	PUNCT
ajlm-1713	5	4	higher	high	ADJ
ajlm-1713	5	5	proportion	proportion	NOUN
ajlm-1713	5	6	of	of	ADP
ajlm-1713	5	7	non	non	ADJ
ajlm-1713	5	8	-	-	ADJ
ajlm-1713	5	9	classical	classical	ADJ
ajlm-1713	5	10	and	and	CCONJ
ajlm-1713	5	11	intermediate	intermediate	ADJ
ajlm-1713	5	12	monocytes	monocyte	NOUN
ajlm-1713	5	13	in	in	ADP
ajlm-1713	5	14	newly	newly	ADV
ajlm-1713	5	15	diagnosed	diagnose	VERB
ajlm-1713	5	16	multiple	multiple	ADJ
ajlm-1713	5	17	myeloma	myeloma	NOUN
ajlm-1713	5	18	patients	patient	NOUN
ajlm-1713	5	19	in	in	ADP
ajlm-1713	5	20	egypt	egypt	PROPN
ajlm-1713	5	21	:	:	PUNCT
ajlm-1713	5	22	a	a	DET
ajlm-1713	5	23	possible	possible	ADJ
ajlm-1713	5	24	prognostic	prognostic	ADJ
ajlm-1713	5	25	marker	marker	NOUN
ajlm-1713	5	26	asmaa	asmaa	PROPN
ajlm-1713	5	27	m.	m.	PROPN
ajlm-1713	5	28	zahran	zahran	PROPN
ajlm-1713	5	29	,	,	PUNCT
ajlm-1713	5	30	hanaa	hanaa	PROPN
ajlm-1713	5	31	nafady	nafady	ADV
ajlm-1713	5	32	-	-	PUNCT
ajlm-1713	5	33	hego	hego	ADJ
ajlm-1713	5	34	,	,	PUNCT
ajlm-1713	5	35	sawsan	sawsan	ADJ
ajlm-1713	5	36	m.	m.	PROPN
ajlm-1713	5	37	moeen	moeen	PROPN
ajlm-1713	5	38	,	,	PUNCT
ajlm-1713	5	39	hanan	hanan	PROPN
ajlm-1713	5	40	a.	a.	PROPN
ajlm-1713	5	41	eltyb	eltyb	PROPN
ajlm-1713	5	42	,	,	PUNCT
ajlm-1713	5	43	mohammed	mohammed	PROPN
ajlm-1713	5	44	m.	m.	PROPN
ajlm-1713	5	45	wahman	wahman	PROPN
ajlm-1713	5	46	,	,	PUNCT
ajlm-1713	5	47	asmaa	asmaa	PROPN
ajlm-1713	5	48	nafady	nafady	ADV
ajlm-1713	5	49	published	publish	VERB
ajlm-1713	5	50	:	:	PUNCT
ajlm-1713	5	51	25	25	NUM
ajlm-1713	5	52	mar	mar	PROPN
ajlm-1713	5	53	.	.	PROPN
ajlm-1713	6	1	2022	2022	NUM
ajlm-1713	6	2	copyright	copyright	NOUN
ajlm-1713	6	3	:	:	PUNCT
ajlm-1713	6	4	©	©	PROPN
ajlm-1713	6	5	2022	2022	NUM
ajlm-1713	6	6	.	.	PUNCT
ajlm-1713	7	1	the	the	DET
ajlm-1713	7	2	author(s	author(s	PROPN
ajlm-1713	7	3	)	)	PUNCT
ajlm-1713	7	4	.	.	PUNCT
ajlm-1713	8	1	licensee	licensee	NOUN
ajlm-1713	8	2	:	:	PUNCT
ajlm-1713	8	3	aosis	aosis	NOUN
ajlm-1713	8	4	.	.	PUNCT
ajlm-1713	9	1	this	this	PRON
ajlm-1713	9	2	is	be	AUX
ajlm-1713	9	3	an	an	DET
ajlm-1713	9	4	open	open	ADJ
ajlm-1713	9	5	access	access	NOUN
ajlm-1713	9	6	article	article	NOUN
ajlm-1713	9	7	distributed	distribute	VERB
ajlm-1713	9	8	under	under	ADP
ajlm-1713	9	9	the	the	DET
ajlm-1713	9	10	terms	term	NOUN
ajlm-1713	9	11	of	of	ADP
ajlm-1713	9	12	the	the	DET
ajlm-1713	9	13	creative	creative	ADJ
ajlm-1713	9	14	commons	common	NOUN
ajlm-1713	9	15	attribution	attribution	NOUN
ajlm-1713	9	16	license	license	NOUN
ajlm-1713	9	17	,	,	PUNCT
ajlm-1713	9	18	which	which	PRON
ajlm-1713	9	19	permits	permit	VERB
ajlm-1713	9	20	unrestricted	unrestricted	ADJ
ajlm-1713	9	21	use	use	NOUN
ajlm-1713	9	22	,	,	PUNCT
ajlm-1713	9	23	distribution	distribution	NOUN
ajlm-1713	9	24	,	,	PUNCT
ajlm-1713	9	25	and	and	CCONJ
ajlm-1713	9	26	reproduction	reproduction	NOUN
ajlm-1713	9	27	in	in	ADP
ajlm-1713	9	28	any	any	DET
ajlm-1713	9	29	medium	medium	NOUN
ajlm-1713	9	30	,	,	PUNCT
ajlm-1713	9	31	provided	provide	VERB
ajlm-1713	9	32	the	the	DET
ajlm-1713	9	33	original	original	ADJ
ajlm-1713	9	34	work	work	NOUN
ajlm-1713	9	35	is	be	AUX
ajlm-1713	9	36	properly	properly	ADV
ajlm-1713	9	37	cited	cite	VERB
ajlm-1713	9	38	.	.	PUNCT
ajlm-1713	10	1	in	in	ADP
ajlm-1713	10	2	the	the	DET
ajlm-1713	10	3	published	publish	VERB
ajlm-1713	10	4	article	article	NOUN
ajlm-1713	10	5	,	,	PUNCT
ajlm-1713	10	6	zahran	zahran	PROPN
ajlm-1713	10	7	am	be	AUX
ajlm-1713	10	8	,	,	PUNCT
ajlm-1713	10	9	nafady	nafady	ADJ
ajlm-1713	10	10	-	-	PUNCT
ajlm-1713	10	11	hego	hego	ADJ
ajlm-1713	10	12	h	h	NOUN
ajlm-1713	10	13	,	,	PUNCT
ajlm-1713	10	14	moeen	moeen	PROPN
ajlm-1713	10	15	sm	sm	PROPN
ajlm-1713	10	16	,	,	PUNCT
ajlm-1713	10	17	eltyb	eltyb	VERB
ajlm-1713	10	18	ha	ha	INTJ
ajlm-1713	10	19	,	,	PUNCT
ajlm-1713	10	20	wahman	wahman	ADJ
ajlm-1713	10	21	mm	mm	PROPN
ajlm-1713	10	22	,	,	PUNCT
ajlm-1713	10	23	nafady	nafady	ADJ
ajlm-1713	10	24	a.	a.	NOUN
ajlm-1713	10	25	higher	high	ADJ
ajlm-1713	10	26	proportion	proportion	NOUN
ajlm-1713	10	27	of	of	ADP
ajlm-1713	10	28	non	non	ADJ
ajlm-1713	10	29	-	-	ADJ
ajlm-1713	10	30	classical	classical	ADJ
ajlm-1713	10	31	and	and	CCONJ
ajlm-1713	10	32	intermediate	intermediate	ADJ
ajlm-1713	10	33	monocytes	monocyte	NOUN
ajlm-1713	10	34	in	in	ADP
ajlm-1713	10	35	newly	newly	ADV
ajlm-1713	10	36	diagnosed	diagnose	VERB
ajlm-1713	10	37	multiple	multiple	ADJ
ajlm-1713	10	38	myeloma	myeloma	NOUN
ajlm-1713	10	39	patients	patient	NOUN
ajlm-1713	10	40	in	in	ADP
ajlm-1713	10	41	egypt	egypt	PROPN
ajlm-1713	10	42	:	:	PUNCT
ajlm-1713	10	43	a	a	DET
ajlm-1713	10	44	possible	possible	ADJ
ajlm-1713	10	45	prognostic	prognostic	ADJ
ajlm-1713	10	46	marker	marker	NOUN
ajlm-1713	10	47	.	.	PUNCT
ajlm-1713	11	1	afr	afr	PROPN
ajlm-1713	11	2	j	j	PROPN
ajlm-1713	11	3	lab	lab	PROPN
ajlm-1713	11	4	med	med	PROPN
ajlm-1713	11	5	.	.	PUNCT
ajlm-1713	12	1	2021;10(1	2021;10(1	NUM
ajlm-1713	12	2	)	)	PUNCT
ajlm-1713	12	3	,	,	PUNCT
ajlm-1713	12	4	a1296	a1296	PROPN
ajlm-1713	12	5	.	.	NOUN
ajlm-1713	12	6	https://doi.org/10.4102/ajlm.v10i1.1296	https://doi.org/10.4102/ajlm.v10i1.1296	NUM
ajlm-1713	12	7	,	,	PUNCT
ajlm-1713	12	8	there	there	PRON
ajlm-1713	12	9	was	be	VERB
ajlm-1713	12	10	an	an	DET
ajlm-1713	12	11	error	error	NOUN
ajlm-1713	12	12	on	on	ADP
ajlm-1713	12	13	page	page	NOUN
ajlm-1713	12	14	3	3	NUM
ajlm-1713	12	15	under	under	ADP
ajlm-1713	12	16	the	the	DET
ajlm-1713	12	17	‘	'	PUNCT
ajlm-1713	12	18	results	result	NOUN
ajlm-1713	12	19	’	'	PUNCT
ajlm-1713	12	20	section	section	NOUN
ajlm-1713	12	21	.	.	PUNCT
ajlm-1713	13	1	the	the	DET
ajlm-1713	13	2	mean	mean	ADJ
ajlm-1713	13	3	age	age	NOUN
ajlm-1713	13	4	of	of	ADP
ajlm-1713	13	5	the	the	DET
ajlm-1713	13	6	mm	mm	PROPN
ajlm-1713	13	7	patients	patient	NOUN
ajlm-1713	13	8	should	should	AUX
ajlm-1713	13	9	be	be	AUX
ajlm-1713	13	10	63.5	63.5	NUM
ajlm-1713	13	11	as	as	ADP
ajlm-1713	13	12	per	per	ADP
ajlm-1713	13	13	table	table	NOUN
ajlm-1713	13	14	1	1	NUM
ajlm-1713	13	15	instead	instead	ADV
ajlm-1713	13	16	of	of	ADP
ajlm-1713	13	17	6.35	6.35	NUM
ajlm-1713	13	18	.	.	PUNCT
ajlm-1713	14	1	the	the	DET
ajlm-1713	14	2	first	first	ADJ
ajlm-1713	14	3	paragraph	paragraph	NOUN
ajlm-1713	14	4	under	under	ADP
ajlm-1713	14	5	the	the	DET
ajlm-1713	14	6	‘	'	PUNCT
ajlm-1713	14	7	results	result	NOUN
ajlm-1713	14	8	’	'	PUNCT
ajlm-1713	14	9	section	section	NOUN
ajlm-1713	14	10	is	be	AUX
ajlm-1713	14	11	updated	update	VERB
ajlm-1713	14	12	to	to	PART
ajlm-1713	14	13	:	:	PUNCT
ajlm-1713	14	14	results	result	NOUN
ajlm-1713	14	15	baseline	baseline	VERB
ajlm-1713	14	16	characteristics	characteristic	NOUN
ajlm-1713	14	17	of	of	ADP
ajlm-1713	14	18	newly	newly	ADV
ajlm-1713	14	19	diagnosed	diagnose	VERB
ajlm-1713	14	20	multiple	multiple	ADJ
ajlm-1713	14	21	myeloma	myeloma	NOUN
ajlm-1713	14	22	patients	patient	NOUN
ajlm-1713	14	23	and	and	CCONJ
ajlm-1713	14	24	healthy	healthy	ADJ
ajlm-1713	14	25	controls	control	NOUN
ajlm-1713	14	26	the	the	DET
ajlm-1713	14	27	mean	mean	ADJ
ajlm-1713	14	28	age	age	NOUN
ajlm-1713	14	29	of	of	ADP
ajlm-1713	14	30	the	the	DET
ajlm-1713	14	31	mm	mm	PROPN
ajlm-1713	14	32	patients	patient	NOUN
ajlm-1713	14	33	was	be	AUX
ajlm-1713	14	34	63.5	63.5	NUM
ajlm-1713	14	35	±	±	NUM
ajlm-1713	14	36	4.07	4.07	NUM
ajlm-1713	14	37	years	year	NOUN
ajlm-1713	14	38	,	,	PUNCT
ajlm-1713	14	39	and	and	CCONJ
ajlm-1713	14	40	the	the	DET
ajlm-1713	14	41	number	number	NOUN
ajlm-1713	14	42	of	of	ADP
ajlm-1713	14	43	men	man	NOUN
ajlm-1713	14	44	(	(	PUNCT
ajlm-1713	14	45	13	13	NUM
ajlm-1713	14	46	)	)	PUNCT
ajlm-1713	14	47	was	be	AUX
ajlm-1713	14	48	double	double	ADJ
ajlm-1713	14	49	that	that	PRON
ajlm-1713	14	50	of	of	ADP
ajlm-1713	14	51	women	woman	NOUN
ajlm-1713	14	52	(	(	PUNCT
ajlm-1713	14	53	7	7	NUM
ajlm-1713	14	54	)	)	PUNCT
ajlm-1713	14	55	(	(	PUNCT
ajlm-1713	14	56	table	table	NOUN
ajlm-1713	14	57	1	1	NUM
ajlm-1713	14	58	)	)	PUNCT
ajlm-1713	14	59	.	.	PUNCT
ajlm-1713	15	1	the	the	DET
ajlm-1713	15	2	proportion	proportion	NOUN
ajlm-1713	15	3	of	of	ADP
ajlm-1713	15	4	plasma	plasma	NOUN
ajlm-1713	15	5	cells	cell	NOUN
ajlm-1713	15	6	in	in	ADP
ajlm-1713	15	7	bone	bone	NOUN
ajlm-1713	15	8	marrow	marrow	NOUN
ajlm-1713	15	9	was	be	AUX
ajlm-1713	15	10	39.7	39.7	NUM
ajlm-1713	15	11	%	%	NOUN
ajlm-1713	15	12	±	±	NUM
ajlm-1713	15	13	3.7	3.7	NUM
ajlm-1713	15	14	%	%	NOUN
ajlm-1713	15	15	and	and	CCONJ
ajlm-1713	15	16	that	that	PRON
ajlm-1713	15	17	of	of	ADP
ajlm-1713	15	18	the	the	DET
ajlm-1713	15	19	monoclonal	monoclonal	NOUN
ajlm-1713	15	20	band	band	NOUN
ajlm-1713	15	21	(	(	PUNCT
ajlm-1713	15	22	m	m	NOUN
ajlm-1713	15	23	-	-	NOUN
ajlm-1713	15	24	protein	protein	NOUN
ajlm-1713	15	25	)	)	PUNCT
ajlm-1713	15	26	was	be	AUX
ajlm-1713	15	27	4.44	4.44	NUM
ajlm-1713	15	28	g	g	NOUN
ajlm-1713	15	29	/	/	SYM
ajlm-1713	15	30	dl	dl	PROPN
ajlm-1713	15	31	±	±	NUM
ajlm-1713	15	32	2.8	2.8	NUM
ajlm-1713	15	33	g	g	NOUN
ajlm-1713	15	34	/	/	SYM
ajlm-1713	15	35	dl	dl	PROPN
ajlm-1713	15	36	.	.	PUNCT
ajlm-1713	16	1	the	the	DET
ajlm-1713	16	2	authors	author	NOUN
ajlm-1713	16	3	apologise	apologise	VERB
ajlm-1713	16	4	for	for	ADP
ajlm-1713	16	5	this	this	DET
ajlm-1713	16	6	error	error	NOUN
ajlm-1713	16	7	.	.	PUNCT
ajlm-1713	17	1	the	the	DET
ajlm-1713	17	2	correction	correction	NOUN
ajlm-1713	17	3	does	do	AUX
ajlm-1713	17	4	not	not	PART
ajlm-1713	17	5	change	change	VERB
ajlm-1713	17	6	the	the	DET
ajlm-1713	17	7	study	study	NOUN
ajlm-1713	17	8	’s	’s	PART
ajlm-1713	17	9	findings	finding	NOUN
ajlm-1713	17	10	of	of	ADP
ajlm-1713	17	11	significance	significance	NOUN
ajlm-1713	17	12	or	or	CCONJ
ajlm-1713	17	13	overall	overall	ADJ
ajlm-1713	17	14	interpretation	interpretation	NOUN
ajlm-1713	17	15	of	of	ADP
ajlm-1713	17	16	the	the	DET
ajlm-1713	17	17	study	study	NOUN
ajlm-1713	17	18	’s	’s	PART
ajlm-1713	17	19	results	result	NOUN
ajlm-1713	17	20	or	or	CCONJ
ajlm-1713	17	21	the	the	DET
ajlm-1713	17	22	scientific	scientific	ADJ
ajlm-1713	17	23	conclusions	conclusion	NOUN
ajlm-1713	17	24	of	of	ADP
ajlm-1713	17	25	the	the	DET
ajlm-1713	17	26	article	article	NOUN
ajlm-1713	17	27	in	in	ADP
ajlm-1713	17	28	any	any	DET
ajlm-1713	17	29	way	way	NOUN
ajlm-1713	17	30	.	.	PUNCT